We found a statistical trend with worse survival for patients with higher LDH levels (HR: 1.74, 95% CI: 0.96-3.13).
← all excerpts
Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.
1
—
—